Groen, Emma J.
van der Noordaa, Marieke E. M.
Schaapveld, Michael
Sonke, Gabe S.
Mann, Ritse M.
van Ramshorst, Mette S.
Lips, Esther H.
Vrancken Peeters, Marie-Jeanne T. F. D.
van Duijnhoven, Frederieke H.
Wesseling, Jelle http://orcid.org/0000-0002-8940-2676
Funding for this research was provided by:
Cancer Research UK and KWF Kankerbestrijding (ref. C38317/A24043)
Article History
Received: 20 November 2020
Accepted: 17 April 2021
First Online: 4 May 2021
Declarations
:
: Dr Sonke reports receiving institutional research support from AstraZeneca, Merck, Novartis, and Roche and Dr Mann from Siemens Healthineers, Medtronic, Bayer Healthcare, BD, Screenpoint Medical, Seno Medical and Transonic Imaging. For the remaining authors, none were declared.
: This retrospective study involving human participants was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board of the NKI-AVL.
: The study used only unidentifiable patient information, and no informed consent was required.
: Not applicable.